The Maternal Health Quality Improvement Act passes in the U.S. House of Representatives


On Monday, September 21, 2020, the House of Representatives unanimously passed the Maternal Health Quality Improvement Act (H.R. 4995).

This legislation seeks to address the country’s maternal morbidity crisis through the implementation of rural obstetric networks, maternal telehealth programs, staff-focused implicit bias training, and integrated health care services for pregnant and postpartum women.

In a statement applauding its passage, the president of the American College of Obstetrics and Gynecologists (ACOG) urged the U.S. Senate to pass and sign the Maternal Health Quality Improvement Act into law by the end of 2020.

“The pandemic has underscored the importance of the Medicaid program, which already plays a critical role in maternity care—covering 43 percent of births nationwide. By also passing H.R. 4996, the House and Senate would support state efforts to extend Medicaid coverage beyond the standard 60 days to one year postpartum and close critical coverage gaps for women after pregnancy,” the statement read.

If signed into law, H.R. 4995 will provide $65 million annually for perinatal quality collaboratives, which unite health care providers to develop and implement programs to address underlying causes of maternal mortality and morbidity. It would also provide medical and nursing schools $5 million annually for courses on reducing and preventing discrimination with implicit bias training.

See ACOG’s full statement here.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.